> Nordic Nanovector delayed the readout from its phase 2b follicular lymphoma trial in response to slow patient enrollment. The delay moves the readout beyond when analysts at Jefferies expect the biotech’s current cash reserves to run dry. Release
> PPF bought a 19.2% stake in CAR-T biotech Autolus. The Czech investment group owns most of another biotech, Sotio. Statement
> Lytix Biopharma appointed Øystein Rekdal as CEO. Rekdal replaces Edwin Klumper, who is taking early retirement. Release
> Poxel shared detailed data from a Japanese phase 3 trial of imeglimin in Type 2 diabetics. Metavant has the rights to the drug in the U.S. and Europe. Statement
> Theranexus enrolled the last subject in a phase 1b trial of its treatment of neurocognitive disorders related to Alzheimer's disease. Release
> Ose Immunotherapeutics received a €5.4 million ($6 million) milestone payment in relation to its Boehringer Ingelheim-partnered SIRPa-antagonist and myeloid checkpoint inhibitor. Statement